BS ReporterHyderabad, 27 March: Dr Reddy's Laboratories Limited and global medical technology company Integra LifeScinces Holdings Corporation announced today that they have entered into an exclusive distribution agreement under which the Hyderabad-based generic pharma major will market and distribute DuraGen Plus and Suturable DurgaGen dural regeneration matrices for use in patients in India.M V Ramana, executive vice president and head of emerging markets and India business at Dr Reddy's said,"We are delighted to partner with Integra LifeSciences. With the launch of DuraGen, we look forward to building our presence in the segment of regenerative technologies and making a difference to the lives of patients undergoing neurosurgery."Commenting on the tie-up, Integra LifeSciences chief financial officer Glenn Coleman stated that this collaboration will allow the company to expand patient access globally and provide innovative regenerative technology solutions to neurosurgeons and ...
Consolidated net profit was down 80% at Rs 126.3 core for the June quarter